A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This primary purpose of this study is to evaluate the safety and efficacy of topiramate
compared with lithium or placebo in the treatment of acute manic or mixed episodes in
patients with Bipolar I Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.